-
1.
公开(公告)号:US20240150319A1
公开(公告)日:2024-05-09
申请号:US18506060
申请日:2023-11-09
发明人: Jian Lin , Anna Ericsson , Ann-Marie Campbell , Gary Gustafson , Zhongguo Wang , R. Bruce Diebold , Susan Ashwell , David R. Lancia, JR. , Justin Andrew Caravella , Wei Lu
IPC分类号: C07D401/12 , A61P35/00 , C07D401/14 , C07D471/04
CPC分类号: C07D401/12 , A61P35/00 , C07D401/14 , C07D471/04 , A61K31/47
摘要: The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula:
where A, U, W1, W2, W3, R1-R6, and R9 are described herein.-
公开(公告)号:US20230125739A1
公开(公告)日:2023-04-27
申请号:US17984069
申请日:2022-11-09
发明人: Jian Lin , Anna Ericsson , Ann-Marie Campbell , Gary Gustafson , Zhongguo Wang , R. Bruce Diebold , Susan Ashwell , David R. Lancia, JR. , Justin Andrew Caravella , Wei Lu
IPC分类号: C07D401/12 , C07D401/14 , C07D471/04 , A61P35/00
摘要: The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where A, U, W1, W2, W3, R1-R6, and R9 are described herein.
-
公开(公告)号:US20210078973A1
公开(公告)日:2021-03-18
申请号:US17101018
申请日:2020-11-23
发明人: Jian Lin , Anna Ericsson , Ann-Marie Campbell , Gary Gustafson , Zhongguo Wang , R. Bruce Diebold , Susan Ashwell , David R. Lancia, JR. , Justin Andrew Caravella , Wei Lu
IPC分类号: C07D401/12 , C07D401/14 , C07D471/04 , A61P35/00
摘要: The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where A, U, W1, W2, W3, R1-R6, and R9 are described herein.
-
公开(公告)号:US10550099B2
公开(公告)日:2020-02-04
申请号:US16290328
申请日:2019-03-01
发明人: Jian Lin , Anna Ericsson , Ann-Marie Campbell , Gary Gustafson , Zhongguo Wang , R. Bruce Diebold , Susan Ashwell , David R. Lancia, Jr. , Justin Andrew Caravella , Wei Lu
IPC分类号: A61K31/506 , C07D401/12 , C07D405/14 , C07D401/14 , C07D417/14 , C07D413/14 , C07D471/04 , C07D409/14 , C07D403/12
摘要: The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where A, B, W1, W2, W3, and R1-R6 are described herein.
-
5.
公开(公告)号:US20190263778A1
公开(公告)日:2019-08-29
申请号:US16290240
申请日:2019-03-01
发明人: Jian Lin , Anna Ericsson , Ann-Marie Campbell , Gary Gustafson , Zhongguo Wang , R. Bruce Diebold , Susan Ashwell , David R. Lancia, JR. , Justin Andrew Caravella , Wei Lu
IPC分类号: C07D401/12 , C07D471/04 , A61P35/00 , C07D401/14
摘要: The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where A, U, W1, W2, W3, R1-R6, and R9 are described herein.
-
公开(公告)号:US11498913B2
公开(公告)日:2022-11-15
申请号:US17101018
申请日:2020-11-23
发明人: Jian Lin , Anna Ericsson , Ann-Marie Campbell , Gary Gustafson , Zhongguo Wang , R. Bruce Diebold , Susan Ashwell , David R. Lancia, Jr. , Justin Andrew Caravella , Wei Lu
IPC分类号: C07D401/12 , C07D401/14 , C07D471/04 , A61P35/00 , A61K31/47
摘要: The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where A, U, W1, W2, W3, R1-R6, and R9 are described herein.
-
公开(公告)号:US10889567B2
公开(公告)日:2021-01-12
申请号:US16712951
申请日:2019-12-12
发明人: Jian Lin , Anna Ericsson , Ann-Marie Campbell , Gary Gustafson , Zhongguo Wang , R. Bruce Diebold , Susan Ashwell , David R. Lancia, Jr. , Justin Andrew Caravella , Wei Lu
IPC分类号: C07D401/12 , C07D401/14 , C07D471/04 , A61P35/00 , A61K31/47
摘要: The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where A, U, W1, W2, W3, R1-R6, and R9 are described herein.
-
公开(公告)号:US20180134682A1
公开(公告)日:2018-05-17
申请号:US15712446
申请日:2017-09-22
发明人: Jian Lin , Anna Ericsson , Ann-Marie Campbell , Gary Gustafson , Zhongguo Wang , R. Bruce Diebold , Susan Ashwell , David R. Lancia, Jr. , Justin Andrew Caravella , Wei Lu
IPC分类号: C07D401/12 , C07D405/14 , C07D401/14 , C07D403/12 , C07D471/04 , C07D409/14 , C07D413/14 , C07D417/14
CPC分类号: C07D401/12 , C07D401/14 , C07D403/12 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where A, B, W1, W2, W3, and R1-R6 are described herein.
-
公开(公告)号:US20180086733A1
公开(公告)日:2018-03-29
申请号:US15677748
申请日:2017-08-15
发明人: Jian Lin , Anna Ericsson , Ann-Marie Campbell , Gary Gustafson , Zhongguo Wang , R. Bruce Diebold , Susan Ashwell , David R. Lancia, JR. , Justin Andrew Caravella , Wei Lu
IPC分类号: C07D401/12 , C07D417/14 , C07D413/14 , C07D405/14 , C07D401/14 , A61K31/4704
CPC分类号: C07D401/12 , A61K31/4704 , C07D401/14 , C07D405/14 , C07D413/14 , C07D417/14
摘要: The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where A, B, U, V, Z, W1, W2, W3, and R1-R6 are described herein.
-
公开(公告)号:US09902728B2
公开(公告)日:2018-02-27
申请号:US14982127
申请日:2015-12-29
发明人: Stephanos Ioannidis , Adam Charles Talbot , Bruce Follows , Alexandre Joseph Buckmelter , Minghua Wang , Ann-Marie Campbell , Darby Rye Schmidt , David Joseph Guerin , Justin A. Caravella , R. Bruce Diebold , Anna Ericsson , David R. Lancia, Jr.
IPC分类号: A01N43/90 , A61K31/519 , C07D487/00 , C07D487/04 , C07D519/00
CPC分类号: C07D487/04 , A61K31/519 , C07D519/00
摘要: The invention relates to inhibitors of USP7 inhibitors useful in the treatment of cancers, neurodegenerative diseases, immunological disorders, inflammatory disorders, cardiovascular diseases, ischemic diseases, viral infections and diseases, and bacterial infections and diseases, having the Formula: where m, n, X1, X2, R1-R5, R5′ and R6 are described herein.
-
-
-
-
-
-
-
-
-